Poliovirus Vaccine, Live (Oral Route)


Free

E-newsletter

Subscribe to Housecall

Our weekly general interest
e-newsletter keeps you up to date on a wide variety of health topics.

Sign up now

Poliovirus Vaccine, Live (Oral Route)

Drug Information provided by: Micromedex

US Brand Names

  • Orimune

Description

Poliovirus vaccine live oral (OPV) is an active immunizing agent used to prevent poliomyelitis (polio). It works by causing your body to produce its own protection (antibodies) against the virus that causes polio.

Polio is a very serious infection that can cause death. In survivors of poliovirus infection, polio causes paralysis of the muscles, including the muscles that enable you to walk and breathe. A polio infection may leave a person unable to breathe without the help of an iron lung, unable to walk without leg braces, or confined to a wheelchair. There is no cure for polio.

Immunization against polio is recommended for all infants from 6 to 12 weeks of age, all children, all teenagers up to 18 years of age, and certain adults who are at greater risk for exposure to polioviruses than the general population.

This vaccine is to be administered only by or under the supervision of your doctor or other healthcare professional.

Routine production of oral poliovirus vaccine (OPV) has been discontinued in the United States; an emergency stockpile is maintained in the event of a poliovirus outbreak.

This product is available in the following dosage forms:

  • Solution
Before Using
DR601137 Portions of this document last updated: Nov. 1, 2012

Source: Drug Information provided by: Micromedex

Copyright © 2013 Thomson Healthcare Inc. All rights reserved. Information is for End User's use only and may not be sold, redistributed or otherwise used for commercial purposes.

Advertisement


Text Size: smaller largerlarger